Edition:
United Kingdom

Intersect ENT Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

41.75USD
20 Apr 2018
Change (% chg)

$0.20 (+0.48%)
Prev Close
$41.55
Open
$41.70
Day's High
$42.20
Day's Low
$41.65
Volume
53,944
Avg. Vol
59,033
52-wk High
$42.20
52-wk Low
$17.05

Select another date:

Tue, Feb 27 2018

BRIEF-Intersect ENT Q4 Revenue $29.5 Million

* INTERSECT ENT REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-Intersect ENT Reports Preliminary Q4 And Year 2017 Revenue

* - CO CONTINUES TO EXPECT TO LAUNCH SINUVA COMMERCIALLY IN Q2 OF 2018

BRIEF-‍James Flynn​ reports 5.92 pct passive stake in Intersect ENT

* ‍James Flynn​ reports 5.92 percent passive stake in Intersect ENT as of Nov 6 - SEC filing Source text : (http://bit.ly/2jwmJXW) Further company coverage:

BRIEF-FDA performs pre-approval inspection of Intersect ENT's menlo park facility

* FDA performs pre-approval inspection of Intersect ENT's menlo park facility

BRIEF-Intersect ENT Inc reports Q3 revenue $22.3 million

* Intersect ENT Inc - ‍outlook for 2017 gross margin continues to be about 84%​

Select another date: